Notices. Notice
343 words·~2 min read·
/register/2019/02/11/2019-01812·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2012-N-0438; FDA-2018-D-1592; FDA-2014-D-2138; FDA-2018-N-0180; FDA-2014-N-1960; FDA-2015-N-1837; and FDA-2016-D-4308] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB Control No. Date approval expires Recommendations for Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by New Plant Varieties Intended for Food Use 0910-0583 10/31/2021 Guidance for Industry on Controlled Correspondence Related to Generic Drug Development 0910-0797 10/31/2021 Guidance for Industry on Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act 0910-0800 10/31/2021 Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications 0910-0810 10/31/2021 MedWatch: Adverse Event and Product Experience Reporting System (Paper-Based) 0910-0291 11/30/2021 Electronic User Fee Payment Form Requests 0910-0805 11/30/2021 Labeling of Red Blood Cell Units with Historical Antigen Typing Results 0910-0862 11/30/2021 Postmarketing Adverse Drug Experience Reporting 0910-0230 12/31/2021 Dated: February 5, 2019. Lowell J. Schiller, Acting Associate Commissioner for Policy. [FR Doc. 2019-01812 Filed 2-8-19; 8:45 am]
Connectionstraces to 1
Traces to 1 document